Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1198 of 5804
-
Diabetes cookie trial: could a daily snack lower blood sugar and save feet?
Disease control Not yet recruitingThe goal of this randomized controlled trial is to learn if GlucoBites functional cookies containing Gynura procumbens can help improve blood sugar control and lower the risk of diabetic foot ulcers in adults with type 2 diabetes. The main questions are: * Do GlucoBites cookies…
Phase: NA • Sponsor: Andina Setyawati • Aim: Disease control
Last updated Jun 26, 2026 12:48 UTC
-
New drug aims to fix chemo side effect in breast cancer patients
Disease control Not yet recruitingThe primary study objective: To evaluate the efficacy of romiplostim (N01) in the treatment of chemotherapy-induced thrombocytopenia (CIT) in breast cancer patients by assessing the proportion of patients whose platelet count recovers to ≥100×10⁹/L after two weeks of treatment. …
Phase: NA • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Jun 26, 2026 14:36 UTC
-
Vaccine shield lasts years in kids: new study confirms
⭐️ VACCINE ⭐️ CompletedTo determine the long-term immunogenicity more than 5 years after EnVAX-A71 vaccination in the pediatric population aged 2 months to \<6 years when first vaccinated.
Sponsor: Enimmune Corporation • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 13:05 UTC
-
New pill aims to keep lymphoma away after CAR-T
Disease control Not yet recruitingThis study is a single-center, Phase IV clinical trial designed to collect and analyze data on the efficacy and safety of zanubrutinib as maintenance therapy following CAR-T cell therapy in subjects with non-Hodgkin B-cell lymphoma.
Sponsor: Beijing GoBroad Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
New drug may help elderly MG patients ditch harmful steroids
Disease control Recruiting nowGeneralized Myasthenia Gravis (gMG) is a rare chronic autoimmune disorder causing muscle weakness and fatigue, primarily due to autoantibodies that disrupt neuromuscular junction function. The most common antibodies target nicotinic acetylcholine receptors (AChR), with others suc…
Phase: PHASE4 • Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Personalized diet after stroke may save lives, large trial tests
Disease control Recruiting nowThis study evaluate the impact of early personalized nutritional management on 1-month mortality after acute stroke. In the randomised centres of the interventional group (early personalized nutritional management), each patient will be assessed by a dietician within 2 days of s…
Phase: NA • Sponsor: University Hospital, Angers • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
New radiation approach aims to safely treat Hard-to-Reach lung tumors
Disease control Recruiting nowThe objective of this study is to enhance the safety profile of SAbR in ultra-central tumors of the lung (primary or metastatic) without compromising its effectiveness.
Phase: EARLY_PHASE1 • Sponsor: University of Texas Southwestern Medical Center • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
New swim program aims to prevent drowning in autistic kids
Disease control Recruiting nowAquOTic is an evidence-based, occupational therapy-led intervention designed to enhance water competency and swim safety skills in children on the autism spectrum. The 10-week program consists of weekly 60-minute group sessions, each including six children paired in a 1:1 ratio w…
Phase: NA • Sponsor: Ohio State University • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
New hope for eye cancer: targeted drug combo shows promise in early trial
Disease control OngoingThis is a phase II, prospective clinical study to evaluate the efficacy and safety of Orelabrutinib combined with Low-Dose Radiotherapy or Rituximab in the treatment of Ocular Adnexal MALT Lymphoma
Phase: PHASE2 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
New drug aims to slow kidney damage in rare disease
Disease control Recruiting nowThe primary objective of this study is to evaluate the efficacy of ALXN1920 compared with placebo in participants with PMN who are at a high risk for disease progression using 24-hour urine protein creatinine ratio (UPCR).
Phase: PHASE2 • Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Heart showdown: which diabetes drug wins?
Disease control CompletedInvestigators are building an empirical evidence base for real world data through large-scale emulation of randomized controlled trials. The investigators' goal is to understand for what types of clinical questions real world data analyses can be conducted with confidence and how…
Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
Could a common supplement protect eyesight after retinal detachment?
Disease control Recruiting nowRetinal detachment occurs when fluid separates the retina (a thin, light sensing tissue) from its usual attachment at the back of the eye. If detached, these retinal cells lose their normal blood supply and begin to die, which is the primary cause of vision loss in retinal detach…
Phase: PHASE4 • Sponsor: Center for Eye Research Australia • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
AI-Powered portable MRI could bring epilepsy diagnosis to millions who lack access
Diagnosis OngoingThe global burden of epilepsy is high affecting over 50 million people worldwide. Majority live in low- and middleincome countries (LMICs) where access to diagnosis and treatment is limited. Accurate diagnosis of epilepsy and identification of the underlying cause through brain i…
Phase: NA • Sponsor: University College, London • Aim: Diagnosis
Last updated Jul 25, 2026 00:00 UTC
-
New hope for rare stomach cancer: drug cocktail shows promise in early trial
Disease control Recruiting nowThe goal of this clinical trial is to learn if treatment modality including albumin-bound paclitaxel, oxaliplatin, tegafur,gimeracil and oteracil porassium capsules (SOX) and sintilimab works to treat locally advanced HER2-negative hepatoid adenocarcinoma of stomach. It will also…
Phase: PHASE2 • Sponsor: Peking University Cancer Hospital & Institute • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Bionic ear for balance? new implant aims to steady wobbly patients
Disease control Recruiting nowThe main aim of this study is to understand if an experimental vestibular implant system can improve balance performance. The system consists of a vestibular implant combined with a cochlear implant sound processor and programming software. The implant is designed to preserve hea…
Phase: NA • Sponsor: Cochlear • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Immunotherapy drug aims to keep adrenocortical cancer at bay
Disease control Recruiting nowThis clinical trial is a single-arm, non-randomized, prospective phase II study. The study aims to evaluate if the maintenance immunotherapy with cemiplimab in patients with AdrenoCortical Carcinoma (ACC), who obtained disease response or stabilization after first-line chemother…
Phase: PHASE2 • Sponsor: Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Could ultrasound replace radioactive dye for cancer staging?
Diagnosis Recruiting nowThis is a prospective single-center interventional non-inferiority study where subjects are participating for one day for patients 18 years or older with melanoma, breast cancer or head \& neck cancer (including melanoma of head and neck area) and scheduled for a surgical SN proc…
Phase: PHASE2, PHASE3 • Sponsor: The Netherlands Cancer Institute • Aim: Diagnosis
Last updated Jun 27, 2026 08:07 UTC
-
Spinal stimulation and special air may help spinal injury patients breathe easier
Disease control Recruiting nowSpinal cord injuries (SCI) can seriously affect a person's ability to breathe. This happens because the injury can damage the nerves that control the muscles used for breathing. As a result, people with SCI often face breathing problems, a higher risk of lung infections, and even…
Phase: NA • Sponsor: Thomas Jefferson University • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
AI could revolutionize severe pneumonia diagnosis
Knowledge-focused OngoingSevere pneumonia (SP) is a critical illness characterized by complex etiology, rapid progression, and high mortality. Its precision diagnosis and treatment face two core challenges. First, traditional etiological diagnostic methods (such as culture, serology, PCR) suffer from low…
Sponsor: Guangzhou Medical University • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:01 UTC
-
Real-World data shows mepolizumab may keep rare vasculitis in check Long-Term
Disease control CompletedThis observational study aims to evaluate the long-term effectiveness and safety of mepolizumab 300 mg/4 weeks in adults with eosinophilic granulomatosis with polyangiitis (EGPA) in the European real-life setting. The main questions it aims to answer are: * How effective is mep…
Sponsor: European EGPA Study Group • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC